Dewpoint Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-09-23. The offering totals $59.1M, of which $59.1M was reported sold. Industry: Biotechnology.
Showing 25 of 40 people.
| Name | Role | Location |
|---|---|---|
| Srinivas Akkaraju, M.D., Ph.D. | Director | Boston, MA |
| Regina Barzilay, Ph.D. | Director | Boston, MA |
| Olivier Brandicourt, M.D. | Director | Boston, MA |
| Guiseppe A Ciaramella, Ph,D. | Director | Boston, MA |
| Anthony A Hyman, Ph.D. | Director | Boston, MA |
| Mark A Murcko, Ph.D. | Director | Boston, MA |
| Amir H Nashat, Ph.D. | Director | Boston, MA |
| Ameet Nathwani, M.D. | Director | Boston, MA |
| Fabio H Pucci, Ph.D. | Director | Boston, MA |
| Lori A Escobedo | Executive Officer | Boston, MA |
| Isaac A Klein, M.D., Ph.D. | Executive Officer | Boston, MA |
| Elisabeth A Leiderman | Executive Officer | Boston, MA |
| Ameet Nathwani, M.D. | Executive Officer | Boston, MA |
| Regina Barzilay, Ph.D. | Related Person | Boston, MA |
| Olivier Brandicourt, M.D. | Related Person | Boston, MA |
| Ameet Nathwani, M.D. | Related Person | Boston, MA |
| Srinivas Akkaraju, M.D., Ph.D. | Related Person | Boston, MA |
| Giuseppe H Ciaramella, Ph.D. | Director | Boston, MA |
| Joel D Sendek | Executive Officer | Boston, MA |
| Srinivas H Akkaraju, M.D., Ph.D. | Director | Boston, MA |
| Ameet A Nathwani, M.D. | Director | Boston, MA |
| Ameet A Nathwani, M.D. | Executive Officer | Boston, MA |
| Olivier H Brandicourt, M.D. | Director | Boston, MA |
| Juergen A Eckhardt, M.D. | Director | Boston, MA |
| Amir H Nashat | Director | Boston, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-07-13 | D/A | $82.3M | $77.2M |
| 2022-02-04 | D | $150.0M | $150.0M |
| 2020-11-02 | D | $77.1M | $77.1M |